← Human Trials & Peer-Reviewed Studies
The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial.
Plain-language guide to PMID 33110042 (2020): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 20,050 women.
Key Facts
- PMID
- 33110042
- Journal
- Menopause (New York, N.Y.)
- Year
- 2020
- Study type
- Randomized Controlled Trial
- Authors
- Nudy M et al. (14 authors)
- DOI
- 10.1097/GME.0000000000001667
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
Who Took Part
The abstract describes 20,050 women taking part.
By PubMed's age tags, the people studied were middle-aged adults and older adults, women only.
This study included 20,050 women (median follow-up of 7 y).
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
Some women received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
MS included: hot flashes, night sweats, dizziness, heart racing, tremors, feeling restless, feeling tired, difficulty concentrating, forgetfulness, mood swings, vaginal dryness, breast tenderness, migraine, and waking up several times at night.
Associations between VMS severity and nMS with outcomes were tested.
What Was Measured
The subject headings attached to it are Calcium, Hot Flashes, Menopause, Outcome Assessment, Health Care, Postmenopause, Vitamin D and Women's Health.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 20,050 women.
With several hundred people or more, it is a fairly large study for this kind of research.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2020 (Menopause (New York, N.Y.)), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.